Publications

SPECIAL CONFERENCE – HEALTH OUTCOMES IN EUROPE: THE QALY CONTROVERSY
New European Guidelines in Cost-Effectiveness Assessment – 25th January 2013 – Brussels, Belgium

Click on the title to download the presentation.

What is Quality Adjusted Life Years? – Dr. Ariel BERESNIAK, Data Mining International, Switzerland

Hurdles to Access Innovation in Europe – Jacqueline BOWMAN, EPPOSI, Belgium

QALYs and Equity: Perspective from Patients Associations – Alastair KENT, Genetic Alliance, UK

QALY-based Appraisals and Rare Diseases – François HOUYEZ, EURORDIS, France

QALY and Pharmaceutical Assessment – Dr. Ansgar HEBBORN, Roche, Switzerland

QALY and Medical Device Assessment – Sophie CROS, EUCOMED – ABBOTT VASCULAR, Belgium

The QALY Controversy in Germany – Pr. Dr. J. Matthias GRAF von der SCHULENBURG

The QALY Controversy in USA – Pr. Dr. Ivo ABRAHAM, University of Arizona – USA